Prostate Cancer - Results from #22720

Patient selection and pathological outcomes using currently available active surveillance criteria - Abstract July 23, 2013

Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors - Abstract July 23, 2013

Factors associated with adherence to physical activity guidelines in patients with prostate cancer - Abstract July 23, 2013

Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial - Abstract July 23, 2013

Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T - Abstract July 23, 2013

Prostate radiotherapy clinical trial quality assurance: How real should real time review be? (A TROG-OCOG Intergroup Project) - Abstract July 23, 2013

Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups - Abstract July 23, 2013

Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches - Abstract July 23, 2013

Ultraviolet index and racial differences in prostate cancer incidence and mortality - Abstract July 22, 2013

Endurance training in prostate cancer patients treated with androgen deprivation therapy - Abstract July 22, 2013

Prostate tissue characterization/classification in 144 patient population using wavelet and higher order spectra features from transrectal ultrasound images - Abstract July 22, 2013

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density - Abstract July 22, 2013

Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance - Abstract July 22, 2013

Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy - Abstract July 22, 2013

Novel parameter predicting grade 2 rectal bleeding after iodine-125 prostate brachytherapy combined with external beam radiation therapy - Abstract July 22, 2013

Genome-wide investigation of multifocal and unifocal prostate cancer-Are they genetically different? - Abstract July 22, 2013

Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT - Abstract July 22, 2013

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): A phase 3, double-blind randomised trial - Abstract July 22, 2013

Functional and cancer genomics of ASXL family members - Abstract July 19, 2013

Magnetic resonance imaging facilitate appropriate treatment selection of prostate cancer patients - Abstract July 19, 2013

Page 1137 of 1437